|

mFOLFIRINOX Treatment Regimen Clinical Trials

3 actively recruiting trials across 1 location

Also known as: Camptosar, Eloxatin, Fluorouracil, Folinic acid

Pipeline

Phase 2: 2Phase 1/2: 1

Top Sponsors

  • Oncolytics Biotech1
  • Medical College of Wisconsin1
  • Hopital Foch1

Indications

  • Cancer3
  • Squamous Cell Carcinoma of the Anus Stage Unspecified1
  • Anal Cancer Metastatic1
  • Pancreas Neoplasms1
  • Unresectable Pancreatic Carcinoma1

Other2 trials

A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab
Phase 1/2
DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer
Phase 2

Scottsdale, Arizona1 trial

PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples

HonorHealth Medical Group

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.